newsfilter
← Latest News
Business Wire·

Biocept Reports Unaudited 2021 Revenue and Year-End Cash Balance

Biocept, Inc. (NASDAQ:BIOC), a leading provider of molecular diagnostic assays, products and services, reports unaudited net revenue for 2021 of $61.2 million and cash and cash equivalents as of December 31, 2021 of approximately $28 million. "Revenu